JointMedica’s Polymotion Hip Resurfacing System Granted Breakthrough Device Designation

Exactech has announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedica’s Polymotion Hip Resurfacing System. Exactech, a minority shareholder of JointMedica Limited, is collaborating with the United...

Paragon 28 Expands Soft Tissue Portfolio

Paragon 28 Inc., a medical device company exclusively focused on the foot and ankle orthopedic market, has announced an expansion of its soft-tissue portfolio with the launch of its Grappler Suture Anchor System. The Grappler Suture Anchor System provides surgeons an...

National Medical Billing Services Acquires Medi-Corp Inc.

National Medical Billing Services, a health care revenue cycle management (RCM) company serving the surgical market, has acquired Medi-Corp Inc., a nationwide RCM services provider specializing in anesthesia, ASCs and pain management. “This partnership will further...

Ga. Governor Signs Surgical Smoke Legislation

Georgia Governor Brian P. Kemp recently signed several bills designed to benefit health care providers and patients in Georgia. The new laws will also strengthen the state's health care system, according to a news release. One piece of legislation signed into law by...

[Sponsored] Company Showcase: ASP

Sponsored by ASP


Advanced Sterilization Products (ASP) is a leader in infection prevention, dedicated to creating the products, solutions and processes needed by practitioners to protect patients during their most critical moments. ASP is committed to continuously advancing infection prevention technologies that health care depends upon.

In addition, ASP is a trusted partner in sterility assurance. The company backs every product it sells with comprehensive support from clinical educational consultants, in-service training and a full-service warranty.

Terminal Sterilization

The ASP STERRAD systems continue to be the market leader in hydrogen peroxide based low-temperature sterilization with over 20,000 systems installed globally. Health care institutions around the world have trusted STERRAD systems for decades to safely sterilize medical instruments and materials without leaving toxic residue.

Hydrogen peroxide gas plasma sterilization technology helps enhance the safety of patients and sterile processing staff. Gas plasma is documented to actively break down hydrogen peroxide, reducing emissions exposure for sterile processing staff.

ASP’s interconnected hydrogen peroxide sterilization and biological indicator monitoring system guides users to help ensure quick and compliant instrument reprocessing. The STERRAD sterilization system’s proprietary gas plasma sterilization offers the largest list of device validations for sterilization in close partnership with medical device manufacturers. The STERRAD VELOCITY System is the first and only all-in-one biological indicator and process challenge device for ensuring sterility assurance. Through ASP ACCESS Technology, ASP systems communicate together to provide an interconnected system of compliance guidance that combines error prevention features with automated audit-ready record keeping and integration with major ITS providers.

The STERRAD NX System with ALLClear Technology delivers sterility assurance through an upgradeable platform to help maximize clinical, financial and operational outcomes. It is a compact unit offering from the STERRAD Systems platform. It includes two sterilization cycles – standard and advanced – to sterilize a variety of medical devices, supported by device validations working in close collaboration with medical device manufacturers.


The STERRAD 100NX System with ALLClear Technology is one of the latest releases from the STERRAD systems platform, featuring over 25 years of innovation in hydrogen peroxide gas plasma (HPGP) sterilization technology. It currently includes up to four sterilization cycles – standard, express, flex and duo.

The ALLClear Technology within the systems increases sterilization productivity by conditioning the load, checking for moisture and running system diagnostics prior to sterilization cycles to maximize successful cycle runs.

Featuring an upgradeable platform, the STERRAD NX Systems with ALLClear Technology are designed to adapt to the upcoming demands of sterile processing as medical device designs and guidelines evolve over time.


The ASP AEROFLEX Automatic Endoscope Reprocessor (AER) accelerates workflow and enhances compliance to help maximize clinical, financial and operational outcomes.

The ASP AEROFLEX AER is a cost-effective, single-basin system that automates the washing and high-level disinfection cycle of flexible semi-critical endoscopes, increasing productivity and enhancing compliance. It is cleared by the FDA to high-level disinfect flexible, semi-critical endoscopes. Scopes from multiple manufacturers including Olympus, Fuji, Pentax, and others have been qualified on ASP AEROFLEX AER. (For model-specific information or to confirm your scope inventory can be reprocessed with this device, get a consultation and an ASP expert will assist.)

ASP AEROFLEX AER features include:

  • Fast 22-minute cycle time.
  • Exclusive AUTOSURE MRC Monitor: automated verification of MRC prevents OPA concentration monitoring from being skipped or done incorrectly, delivers a definitive pass/fail result and eliminates a manual step from the workflow
  • Intuitive user interface: intuitive navigation menu is quick and easy to learn and operate, helping customers to breeze through operation of the system and guiding them through compliant processing steps
  • Automated record keeping: designed to enhance documentation compliance and simplifies manual record keeping step in the workflow
  • Small footprint
  • Easy to install

Case Study

In line with environmental standards regulating exposure of hydrogen peroxide, a comparison study was conducted to determine the differences in hydrogen peroxide emissions for both STERRAD Systems and STERIS V-PRO sterilizers.

The study was a simple comparison between four low-temperature sterilization systems – two from each manufacturer. The sterilizers from each brand are clinical in-use sterilizers.

The systems tested were the STERRAD 100NX System, the STERRAD NX System, the V-PRO maX and the V-PRO 1 Plus.

The study’s conclusion states that in a continuous hydrogen peroxide emissions monitoring test monitors were placed on the tops and fronts of the sterilizers. The two STERRAD system sterilizers ignite a gas plasma phase resulting in fewer measurable hydrogen peroxide emissions – none greater than 0.3 ppm. In contrast, the STERIS V-PRO 1 Plus and V-PRO maX sterilizers each produced significant hydrogen peroxide emissions, ranging between 5 and 20 ppm each time the chamber door was opened. The location of the sensor which made these measurements implies hydrogen peroxide clouds were emitted directly into the potential breathing zone of the operator who opens the sterilizer door to remove the load. The test results indicate that when the sterilizer doors were opened at the end of their cycles, STERIS V-PRO sterilizers’ hydrogen peroxide emissions were as much as 27 to 67 times more concentrated than those of STERRAD system sterilizers.

The results of the study demonstrate that the STERRAD system, which uses a gas plasma phase to dissociate hydrogen peroxide during the sterilization cycle, had lower hydrogen peroxide emissions compared to STERIS V-PRO sterilizers, which only passes hydrogen peroxide through a catalytic converter. Therefore, STERRAD systems contribute to a safe working environment.

Read the complete case study online at

Study Disclosures and Acknowledgments

The research was designed and executed by Actionable Research, an independent third-party research firm in conjunction with ChemDAQ Inc., a manufacturer of environmental safety monitoring systems. The research sponsor was Advanced Sterilization Products. All data were collected by the ChemDAQ staff.

Important Information: Prior to use, refer to the complete instructions for use supplied with the device(s) for proper use, indications, contraindications, warnings and precautions.

Capitalized product names are trademarks of ASP Global Manufacturing, GmbH.

The third-party trademarks used herein are the properties of their respective owners.



Submit a Comment

Your email address will not be published.